1-7 of 7
David W. Hedley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A204: Flow cytometric assay of proteasome inhibition in whole blood.

Sergei Gulnik, T. Vincent Shankey, Lidice L. Lopez, David W. Hedley, Sue Chow
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A204.
https://doi.org/10.1158/1535-7163.TARG-13-A204
Published: 01 November 2013
View article titled, Abstract A204: Flow cytometric assay of proteasome inhibition in whole blood.
Journal Articles

Abstract B282: The PLK-4 inhibitor CFI-400945 reduces tumor growth in patient-derived pancreatic xenografts.

Ines Lohse, Pinjiang Cao, Trevor Do, Emin Ibrahimov, Ming-Sound Tsao, David W. Hedley
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B282.
https://doi.org/10.1158/1535-7163.TARG-13-B282
Published: 01 November 2013
View article titled, Abstract B282: The PLK-4 inhibitor CFI-400945 reduces tumor growth in patient-derived pancreatic xenografts.
Journal Articles

Abstract A106: A phase 1 study of ENMD‐2076 in patients with relapsed or refractory acute myeloid leukemia (AML)

Karen W. Yee, Joseph Brandwein, Mark D. Minden, Deborah Sanfelice, Sue Chow, David W. Hedley, Aaron D. Schimmer, Andre C. Schuh, Vikas Gupta, Carolyn F. Sidor, Jamie Arnott, Graham Fletcher, Mark Bray, Hsiao‐Wei Tina Chen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A106.
https://doi.org/10.1158/1535-7163.TARG-09-A106
Published: 10 December 2009
View article titled, Abstract A106: A phase 1 study of ENMD‐2076 in patients with relapsed or refractory acute myeloid leukemia (AML)
Journal Articles

Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts

Diana C. Birle, David W. Hedley
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (10): 2494–2502.
https://doi.org/10.1158/1535-7163.MCT-05-0504
Published: 13 October 2006
View article titled, Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts
Open the PDF for Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts in another window
Journal Articles

Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent

Kenneth W. Yip, Emma Ito, Xinliang Mao, P.Y. Billie Au, David W. Hedley, Joseph D. Mocanu, Carlo Bastianutto, Aaron Schimmer, Fei-Fei Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (9): 2234–2240.
https://doi.org/10.1158/1535-7163.MCT-06-0134
Published: 19 September 2006
View article titled, Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent
Open the PDF for Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent in another window
Journal Articles

The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice

Nhu-An Pham, James W. Jacobberger, Aaron D. Schimmer, Pinjiang Cao, Marcella Gronda, David W. Hedley
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (10): 1239–1248.
https://doi.org/10.1158/1535-7163.1239.3.10
Published: 14 October 2004
View article titled, The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice
Open the PDF for The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice in another window
Journal Articles

Effects of the Epidermal Growth Factor Receptor Inhibitor OSI-774, Tarceva, on Downstream Signaling Pathways and Apoptosis in Human Pancreatic Adenocarcinoma

Sylvia S. W. Ng, Ming-Sound Tsao, Trudey Nicklee, David W. Hedley
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (10): 777–783.
Published: 01 August 2002
View article titled, Effects of the Epidermal Growth Factor Receptor Inhibitor OSI-774, Tarceva, on Downstream Signaling Pathways and Apoptosis in Human Pancreatic Adenocarcinoma
Open the PDF for Effects of the Epidermal Growth Factor Receptor Inhibitor OSI-774, Tarceva, on Downstream Signaling Pathways and Apoptosis in Human Pancreatic Adenocarcinoma in another window